{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:57:42Z","timestamp":1790351862839,"version":"4.1.0"},"reference-count":123,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["IK2 CX001785"],"award-info":[{"award-number":["IK2 CX001785"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA118953"],"award-info":[{"award-number":["CA118953"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA163438"],"award-info":[{"award-number":["CA163438"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA236229"],"award-info":[{"award-number":["CA236229"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006447","name":"Universit\u00e4t Z\u00fcrich","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006447","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["IK2 CX001785"],"award-info":[{"award-number":["IK2 CX001785"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["R01 HL169944"],"award-info":[{"award-number":["R01 HL169944"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["K23AR085191"],"award-info":[{"award-number":["K23AR085191"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["K12CA226330"],"award-info":[{"award-number":["K12CA226330"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL164902-02"],"award-info":[{"award-number":["R01 HL164902-02"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jtct.2026.01.009","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:35:14Z","timestamp":1768350914000},"page":"644.e1-644.e19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Toward Better Response Assessment of Cutaneous Chronic Graft-Versus-Host Disease: A Report from the National Institutes of Health Consensus Project Task Force"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2427-3199","authenticated-orcid":false,"given":"Alina","family":"Markova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2600-6390","authenticated-orcid":false,"given":"Stephanie J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Badri","family":"Modi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0396-2005","authenticated-orcid":false,"given":"Emily","family":"Baumrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6375-6129","authenticated-orcid":false,"given":"Rachel K.","family":"Rosenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2850-4740","authenticated-orcid":false,"given":"Eric R.","family":"Tkaczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia S.","family":"Lehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4881-0427","authenticated-orcid":false,"given":"Yoshihiro","family":"Inamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5021-0714","authenticated-orcid":false,"given":"Paul A.","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0001-6438","authenticated-orcid":false,"given":"Kirk R.","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Pidala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9051-1215","authenticated-orcid":false,"given":"Paul","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1725-5184","authenticated-orcid":false,"given":"Iskra","family":"Pusic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0487-2426","authenticated-orcid":false,"given":"Sencer","family":"Goklemez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Stockmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6338-9218","authenticated-orcid":false,"given":"Iago","family":"Pinal-Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5571-2775","authenticated-orcid":false,"given":"Sophie","family":"Paczesny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4538-8817","authenticated-orcid":false,"given":"Andrew","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris M.","family":"Ponce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noa G.","family":"Holtzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najla El","family":"Jurdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven Z.","family":"Pavletic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9111-9354","authenticated-orcid":false,"given":"Edward W.","family":"Cowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jtct.2026.01.009_bib0001","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1056\/NEJMoa2401537","article-title":"Axatilimab in recurrent or refractory chronic graft-versus-host disease","volume":"391","author":"Wolff","year":"2024","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.jtct.2026.01.009_bib0002","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1182\/blood.2021012021","article-title":"Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar study","volume":"138","author":"Cutler","year":"2021","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jtct.2026.01.009_bib0003","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1056\/NEJMoa2033122","article-title":"Ruxolitinib for glucocorticoid-refractory chronic graft-versus-host disease","volume":"385","author":"Zeiser","year":"2021","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.jtct.2026.01.009_bib0004","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1182\/blood-2017-07-793786","article-title":"Ibrutinib for chronic graft-versus-host disease after failure of prior therapy","volume":"130","author":"Miklos","year":"2017","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jtct.2026.01.009_bib0005","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2026.01.009_bib0006","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jtct.2026.01.009_bib0007","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.bbmt.2015.02.025","article-title":"Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 response criteria working group report","volume":"21","author":"Lee","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1016\/j.jtct.2026.01.009_bib0008","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.bbmt.2011.04.002","article-title":"A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change","volume":"17","author":"Mitchell","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jtct.2026.01.009_bib0009","doi-asserted-by":"crossref","first-page":"69.e1","DOI":"10.1016\/j.jtct.2024.12.011","volume":"31","author":"Bhatt","year":"2025","journal-title":"Transplant Cell Ther"},{"issue":"5","key":"10.1016\/j.jtct.2026.01.009_bib0010","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/jdv.12737","article-title":"Consensus on performing skin biopsies, laboratory workup, evaluation of tissue samples and reporting of the results in patients with suspected cutaneous graft-versus-host disease","volume":"29","author":"Hillen","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.jtct.2026.01.009_bib0011","doi-asserted-by":"crossref","first-page":"599","DOI":"10.6004\/jnccn.2020.0021","article-title":"Hematopoietic cell transplantation, version 2.2020, NCCN clinical practice guidelines in oncology","volume":"18","author":"Saad","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"issue":"11","key":"10.1016\/j.jtct.2026.01.009_bib0012","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/DAD.0000000000002841","article-title":"Histopathologic analysis of chronic cutaneous graft-versus-host disease","volume":"46","author":"Alvarado","year":"2024","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jtct.2026.01.009_bib0013","doi-asserted-by":"crossref","unstructured":"Shulman HM, Cardona DM, Greenson JK, et al. NIH consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 pathology working group report. Biol Blood Marrow Transplant. 2015;21(4):589\u2013603.","DOI":"10.1016\/j.bbmt.2014.12.031"},{"issue":"6 Pt 2","key":"10.1016\/j.jtct.2026.01.009_bib0014","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/S0091-6749(97)70009-5","article-title":"Immunohistology of skin and oral biopsies in graft-versus-host disease after bone marrow transplantation and cytokine therapy","volume":"100","author":"Yamada","year":"1997","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.jtct.2026.01.009_bib0015","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jaad.2020.11.006","article-title":"Clinical characteristics and histopathologic changes of morphea: a single-center, retrospective study of 137 patients","volume":"85","author":"Kim","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jtct.2026.01.009_bib0016","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11926-020-00970-z","article-title":"Skin histology in systemic sclerosis: a relevant clinical biomarker","volume":"23","author":"Showalter","year":"2020","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"10.1016\/j.jtct.2026.01.009_bib0017","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40001-019-0377-6","article-title":"Clinical versus histological grading in the assessment of cutaneous graft versus host disease","volume":"24","author":"Hogenes","year":"2019","journal-title":"Eur J Med Res"},{"issue":"suppl 1","key":"10.1016\/j.jtct.2026.01.009_bib0022","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1182\/blood-2023-182198","article-title":"Topical ruxolitinib for chronic cutaneous GvHD: promising results of a phase 2 clinical trial","volume":"142","author":"Markova","year":"2023","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.jtct.2026.01.009_bib0018","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.jtct.2021.06.001","article-title":"National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2020 highly morbid forms report","volume":"27","author":"Wolff","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"4","key":"10.1016\/j.jtct.2026.01.009_bib0019","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1001\/jamadermatol.2022.6624","article-title":"Prognostic value of cutaneous disease severity estimates on survival outcomes in patients with chronic graft-vs-host disease","volume":"159","author":"Baumrin","year":"2023","journal-title":"JAMA Dermatol"},{"issue":"12","key":"10.1016\/j.jtct.2026.01.009_bib0020","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/bmt.2014.188","article-title":"NIH response criteria measures are associated with important parameters of disease severity in patients with chronic GVHD","volume":"49","author":"Curtis","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"25","key":"10.1016\/j.jtct.2026.01.009_bib0021","doi-asserted-by":"crossref","first-page":"5098","DOI":"10.1182\/blood-2012-10-464198","article-title":"Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease","volume":"121","author":"Inamoto","year":"2013","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jtct.2026.01.009_bib0023","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jtct.2023.12.019","article-title":"Phase 2 trial of ruxolitinib cream for chronic cutaneous GvHD","volume":"30","author":"Markova","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"3","key":"10.1016\/j.jtct.2026.01.009_bib0024","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jaad.2017.03.039","article-title":"A prospective, randomized, double-blinded, split-face\/chest study of prophylactic topical dapsone 5% gel versus moisturizer for the prevention of cetuximab-induced acneiform rash","volume":"77","author":"Belum","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.jtct.2026.01.009_bib0025","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1001\/archderm.137.9.1202","article-title":"Tacrolimus ointment in the treatment of chronic cutaneous graft-vs-host disease: a case series of 18 patients","volume":"137","author":"Choi","year":"2001","journal-title":"Arch Dermatol"},{"issue":"9","key":"10.1016\/j.jtct.2026.01.009_bib0026","first-page":"665","article-title":"Topical tacrolimus\u2014a novel treatment alternative for cutaneous chronic graft-versus-host disease","volume":"16","author":"Elad","year":"2003","journal-title":"Transpl Int"},{"issue":"3","key":"10.1016\/j.jtct.2026.01.009_bib0027","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1182\/blood.2019000216","article-title":"Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteria","volume":"134","author":"Cuvelier","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.01.009_bib0028","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jss.2017.08.019","article-title":"Comparison of the Lund and Browder table to computed tomography scan three-dimensional surface area measurement for a pediatric cohort","volume":"221","author":"Rumpf","year":"2018","journal-title":"J Surg Res"},{"issue":"1","key":"10.1016\/j.jtct.2026.01.009_bib0029","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s12519-019-00320-9","article-title":"Overview of juvenile localized scleroderma and its management","volume":"16","author":"Li","year":"2020","journal-title":"World J Pediatr"},{"issue":"1","key":"10.1016\/j.jtct.2026.01.009_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jbcr\/iry050","article-title":"Changing the way we think about burn size estimation","volume":"40","author":"Pham","year":"2019","journal-title":"J Burn Care Res"},{"issue":"5_2","key":"10.1016\/j.jtct.2026.01.009_bib0031","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1001\/archinte.1915.00070240077005","article-title":"Fifth paper the measurement of the surface area of man","volume":"15","author":"DuBois","year":"1915","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.jtct.2026.01.009_bib0032","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1001\/jamasurg.2021.5848","article-title":"Practical computer vision application to compute total body surface area burn: reappraising a fundamental burn injury formula in the modern era","volume":"157","author":"Choi","year":"2022","journal-title":"JAMA Surg"},{"issue":"5","key":"10.1016\/j.jtct.2026.01.009_bib0033","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.burns.2014.11.010","article-title":"Smartphone applications in burns","volume":"41","author":"Wurzer","year":"2015","journal-title":"Burns"},{"issue":"2","key":"10.1016\/j.jtct.2026.01.009_bib0034","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.burns.2019.08.014","article-title":"A comparison study of methods for estimation of a burn surface area: Lund and Browder, e-burn and Mersey Burns","volume":"46","author":"Chong","year":"2020","journal-title":"Burns"},{"issue":"4","key":"10.1016\/j.jtct.2026.01.009_bib0035","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1136\/emermed-2022-212308","article-title":"EasyTBSA as a method for calculating total body surface area burned: a validation study","volume":"40","author":"Colson","year":"2023","journal-title":"Emerg Med J"},{"issue":"8","key":"10.1016\/j.jtct.2026.01.009_bib0036","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.burns.2021.07.007","article-title":"A systematic review of machine learning and automation in burn wound evaluation: a promising but developing frontier","volume":"47","author":"Huang","year":"2021","journal-title":"Burns"},{"issue":"6","key":"10.1016\/j.jtct.2026.01.009_bib0037","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1111\/bjh.18141","article-title":"Artificial intelligence recognition of cutaneous chronic graft-versus-host disease by a deep learning neural network","volume":"197","author":"McNeil","year":"2022","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.jtct.2026.01.009_bib0038","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/jbcr\/irab192","article-title":"A 1% TBSA chart reduces math errors while retaining acceptable first-estimate accuracy","volume":"43","author":"Ray","year":"2022","journal-title":"J Burn Care Res"},{"issue":"9","key":"10.1016\/j.jtct.2026.01.009_bib0049","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.bbmt.2019.05.008","article-title":"Organ changes associated with provider-assessed responses in patients with chronic graft-versus-host disease","volume":"25","author":"Martin","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jtct.2026.01.009_bib0050","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1001\/jamadermatol.2023.6277","article-title":"Patient-reported outcomes and mortality in cutaneous chronic graft-vs-host disease","volume":"160","author":"Baumrin","year":"2024","journal-title":"JAMA Dermatol"},{"issue":"13","key":"10.1016\/j.jtct.2026.01.009_bib0051","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1182\/blood-2012-04-424135","article-title":"Correlation between NIH composite skin score, patient-reported skin score, and outcome: results from the chronic GVHD consortium","volume":"120","author":"Jacobsohn","year":"2012","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.jtct.2026.01.009_bib0052","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1182\/blood-2011-04-350249","article-title":"Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease","volume":"118","author":"Martires","year":"2011","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jtct.2026.01.009_bib0053","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.bbmt.2019.10.019","article-title":"Disability related to chronic graft-versus-host disease","volume":"26","author":"Hamilton","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"10.1016\/j.jtct.2026.01.009_bib0054","doi-asserted-by":"crossref","first-page":"700.e1","DOI":"10.1016\/j.jtct.2022.06.020","article-title":"Correlation of patient-reported outcomes with clinical organ responses: data from the belumosudil chronic graft-versus-host disease studies","volume":"28","author":"Lee","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2026.01.009_bib0055","unstructured":"Guidance for industry patient-reported outcome measures: use in medical product development to support labeling claims 2009. 2009; Available from: https:\/\/www.fda.gov\/media\/77832\/download."},{"issue":"1","key":"10.1016\/j.jtct.2026.01.009_bib0056","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12955-020-01651-2","article-title":"\u201cIs this the GVHD?\u201d A qualitative exploration of quality of life issues in individuals with graft-versus-host disease following allogeneic stem cell transplant and their experiences of a specialist multidisciplinary bone marrow transplant service","volume":"19","author":"de Vere Hunt","year":"2021","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jtct.2026.01.009_bib0057","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.687675","article-title":"\u201cThis graft-vs.-host disease determines my life. That\u2019s it.\u201d\u2014A qualitative analysis of the experiences and needs of allogenic hematopoietic stem cells transplantation survivors in Germany","volume":"9","author":"Parisek","year":"2021","journal-title":"Front Public Health"},{"issue":"17","key":"10.1016\/j.jtct.2026.01.009_bib0058","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1182\/bloodadvances.2024013233","article-title":"Comparison of treatment response measures in cutaneous sclerosis after allogeneic hematopoietic cell transplantation","volume":"8","author":"Pidala","year":"2024","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.jtct.2026.01.009_bib0059","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/art.38293","article-title":"Assessment of joint and fascia manifestations in chronic graft-versus-host disease","volume":"66","author":"Inamoto","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.jtct.2026.01.009_bib0060","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.bbmt.2015.12.026","article-title":"Content validity of the lee chronic graft-versus-host disease symptom scale as assessed by cognitive interviews","volume":"22","author":"Merkel","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"17","key":"10.1016\/j.jtct.2026.01.009_bib0061","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1200\/JCO.2016.71.4410","article-title":"United States population-based estimates of patient-reported outcomes measurement information system symptom and functional status reference values for individuals with cancer","volume":"35","author":"Jensen","year":"2017","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.jtct.2026.01.009_bib0062","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1200\/JCO.2011.40.2362","article-title":"Randomized trial of myeloablative conditioning regimens: busulfan plus cyclophosphamide versus busulfan plus fludarabine","volume":"31","author":"Lee","year":"2013","journal-title":"J Clin Oncol"},{"issue":"24","key":"10.1016\/j.jtct.2026.01.009_bib0063","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1097\/00007632-200012150-00008","article-title":"SF-36 health survey update","volume":"25","author":"Ware","year":"2000","journal-title":"Spine (Phila Pa 1976)"},{"issue":"5","key":"10.1016\/j.jtct.2026.01.009_bib0064","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2020.01.022","article-title":"Systematic review of patient-reported outcome measures in graft-versus-host disease","volume":"26","author":"Kilgour","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2026.01.009_bib0065","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology life quality index (DLQI)\u2014a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"10.1016\/j.jtct.2026.01.009_bib0066","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/1523-1747.ep12365600","article-title":"Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness","volume":"107","author":"Chren","year":"1996","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1016\/j.jtct.2026.01.009_bib0067","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1111\/bjd.17636","article-title":"Validation and reliability of a disease-specific quality-of-life measure in patients with cutaneous lupus erythematosus","volume":"180","author":"Ogunsanya","year":"2019","journal-title":"Br J Dermatol"},{"issue":"7","key":"10.1016\/j.jtct.2026.01.009_bib0068","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/jdv.19059","article-title":"Cross-sectional quantitative validation of the paediatric localized scleroderma quality of life instrument (LoSQI): a disease-specific patient-reported outcome measure","volume":"37","author":"Zigler","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.jtct.2026.01.009_bib0069","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1158\/1078-0432.CCR-15-1443","article-title":"A randomized phase II crossover study of imatinib or rituximab for cutaneous sclerosis after hematopoietic cell transplantation","volume":"22","author":"Arai","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.jtct.2026.01.009_bib0070","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1182\/blood.2024027334","article-title":"Development of the Lee symptom scale-skin sclerosis for chronic GVHD-associated sclerosis","volume":"145","author":"Baumrin","year":"2025","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jtct.2026.01.009_bib0071","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/jamadermatol.2024.5380","article-title":"Outcomes of importance to patients living with cutaneous chronic graft-vs-host disease","volume":"161","author":"Baumrin","year":"2025","journal-title":"JAMA Dermatol"},{"issue":"7","key":"10.1016\/j.jtct.2026.01.009_bib0072","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1136\/annrheumdis-2012-201491","article-title":"Definition of treatment response in rheumatoid arthritis based on the simplified and the clinical disease activity index","volume":"71","author":"Aletaha","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.jtct.2026.01.009_bib0073","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/art.39501","article-title":"The American College of Rheumatology Provisional Composite Response Index for clinical trials in early diffuse cutaneous systemic sclerosis","volume":"68","author":"Khanna","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jtct.2026.01.009_bib0074","unstructured":"Guidance for industry: patient-reported outcome measures: use in medical product development to support labelling claims. 2009 [cited 2024 January 11]; Available from: https:\/\/www.fda.gov\/media\/77832\/download."},{"issue":"12","key":"10.1016\/j.jtct.2026.01.009_bib0075","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/j.jid.2017.06.032","article-title":"Inhibition of beta-catenin signaling in the skin rescues cutaneous adipogenesis in systemic sclerosis: a randomized, double-blind, placebo-controlled trial of C-82","volume":"137","author":"Lafyatis","year":"2017","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.jtct.2026.01.009_bib0076","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jid.2020.07.031","article-title":"Quantifying skin stiffness in graft-versus-host disease, morphea, and systemic sclerosis using acoustic radiation force impulse imaging and shear wave elastography","volume":"141","author":"Cardones","year":"2021","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.jtct.2026.01.009_bib0077","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2214\/AJR.08.1699","article-title":"Musculocutaneous chronic graft-versus-host disease: MRI follow-up of patients undergoing immunosuppressive therapy","volume":"192","author":"Horger","year":"2009","journal-title":"AJR Am J Roentgenol"},{"issue":"21","key":"10.1016\/j.jtct.2026.01.009_bib0078","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1055\/s-0029-1222575","article-title":"[Sclerodermiform chronic graft-versus-host disease after allogenic peripheral blood stem-cell transplantation]","volume":"134","author":"Neid","year":"2009","journal-title":"Dtsch Med Wochenschr"},{"issue":"1","key":"10.1016\/j.jtct.2026.01.009_bib0079","doi-asserted-by":"crossref","first-page":"e417","DOI":"10.1111\/j.1600-0846.2012.00659.x","article-title":"Assessment of chronic sclerodermoid graft-versus-host disease patients, using 20 MHz high-frequency ultrasonography and cutometer methods","volume":"19","author":"Osmola-Mankowska","year":"2013","journal-title":"Skin Res Technol"},{"issue":"8","key":"10.1016\/j.jtct.2026.01.009_bib0080","doi-asserted-by":"crossref","first-page":"e309","DOI":"10.1097\/RLU.0b013e3182816559","article-title":"Imaging findings and therapy response monitoring in chronic sclerodermatous graft-versus-host disease: preliminary data of a simultaneous PET\/MRI approach","volume":"38","author":"Sauter","year":"2013","journal-title":"Clin Nucl Med"},{"issue":"9","key":"10.1016\/j.jtct.2026.01.009_bib0081","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1007\/s00403-023-02626-1","article-title":"Interrater reproducibility of the Myoton and durometer devices to quantify sclerotic chronic graft-versus-host disease","volume":"315","author":"Ghosh","year":"2023","journal-title":"Arch Dermatol Res"},{"issue":"2","key":"10.1016\/j.jtct.2026.01.009_bib0082","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s10067-023-06848-6","article-title":"Performance of myotonometer in the assessment of skin involvement in systemic sclerosis","volume":"43","author":"Ozturk","year":"2024","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jtct.2026.01.009_bib0083","article-title":"Reproducibility and repeatability of the Myoton to quantify sclerotic chronic graft-versus-host disease","author":"Farhadfar","year":"2025","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.jtct.2026.01.009_bib0084","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41409-018-0346-7","article-title":"Non-invasive measurement of sclerosis in cutaneous cGVHD patients with the handheld device Myoton: a cross-sectional study","volume":"54","author":"Chen","year":"2019","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2026.01.009_bib0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.xjidi.2021.100037","article-title":"Optimal biomechanical parameters for measuring sclerotic chronic graft-versus-host disease","volume":"1","author":"Baker","year":"2021","journal-title":"JID Innov"},{"issue":"4","key":"10.1016\/j.jtct.2026.01.009_bib0086","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/s41409-020-01158-w","article-title":"Longitudinal tracking of skin dynamic stiffness to quantify evolution of sclerosis in chronic graft-versus-host disease","volume":"56","author":"Baker","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jtct.2026.01.009_bib0087","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/archdermatol.2009.78","article-title":"Magnetic resonance imaging in sclerotic-type chronic graft-vs-host disease","volume":"145","author":"Clark","year":"2009","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.jtct.2026.01.009_bib0088","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.bbmt.2015.03.006","article-title":"Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease","volume":"21","author":"Baird","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jtct.2026.01.009_bib0089","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.jid.2021.01.004","article-title":"Research techniques made simple: stratum corneum tape stripping","volume":"141","author":"Keurentjes","year":"2021","journal-title":"J Invest Dermatol"},{"issue":"11","key":"10.1016\/j.jtct.2026.01.009_bib0090","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1016\/j.jid.2019.03.1160","article-title":"Side-by-side comparison of skin biopsies and skin tape stripping highlights abnormal stratum corneum in atopic dermatitis","volume":"139","author":"Kim","year":"2019","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1016\/j.jtct.2026.01.009_bib0091","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.jid.2021.09.038","article-title":"Noninvasive tape-stripping with high-resolution RNA profiling effectively captures a preinflammatory state in nonlesional psoriatic skin","volume":"142","author":"Tsoi","year":"2022","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.jtct.2026.01.009_bib0092","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/ard.61.3.237","article-title":"Non-invasive measurement of biomechanical skin properties in systemic sclerosis","volume":"61","author":"Balbir-Gurman","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.jtct.2026.01.009_bib0093","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1517\/17530059.2013.753877","article-title":"Scleroderma: skin stiffness assessment using the stress-strain relationship under progressive suction","volume":"7","author":"Pierard","year":"2013","journal-title":"Expert Opin Med Diagn"},{"key":"10.1016\/j.jtct.2026.01.009_bib0094","doi-asserted-by":"crossref","first-page":"841217","DOI":"10.1155\/2013\/841217","article-title":"In vivo evaluation of the skin tensile strength by the suction method: pilot study coping with hysteresis and creep extension","volume":"2013","author":"Pierard","year":"2013","journal-title":"ISRN Dermatol"},{"key":"10.1016\/j.jtct.2026.01.009_bib0095","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.matbio.2024.02.006","article-title":"A lysyl oxidase-responsive collagen peptide illuminates collagen remodeling in wound healing","volume":"128","author":"Hiebert","year":"2024","journal-title":"Matrix Biol"},{"issue":"1","key":"10.1016\/j.jtct.2026.01.009_bib0096","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1038\/s41467-017-01846-0","article-title":"Novel peptide probes to assess the tensional state of fibronectin fibers in cancer","volume":"8","author":"Arnoldini","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtct.2026.01.009_bib0097","doi-asserted-by":"crossref","DOI":"10.1136\/ard-2024-225773","article-title":"Pathological autoantibody internalisation in myositis","author":"Pinal-Fernandez","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.jtct.2026.01.009_bib0098","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/ard-2022-223792","article-title":"Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor induced myositis","volume":"82","author":"Pinal-Fernandez","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.jtct.2026.01.009_bib0103","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1182\/blood-2013-07-514372","article-title":"Diverse T-cell responses characterize the different manifestations of cutaneous graft-versus-host disease","volume":"123","author":"Bruggen","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jtct.2026.01.009_bib0104","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s40257-017-0306-9","article-title":"Cutaneous graft-versus-host disease: diagnosis and treatment","volume":"19","author":"Strong Rodrigues","year":"2018","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"10.1016\/j.jtct.2026.01.009_bib0105","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/bjd\/ljad402","article-title":"Diverse macrophage populations contribute to distinct manifestations of human cutaneous graft-versus-host disease","volume":"190","author":"Strobl","year":"2024","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.jtct.2026.01.009_bib0106","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1111\/ced.13759","article-title":"Differential expression of interferon-induced genes and other tissue-based biomarkers in acute graft-versus-host disease vs. lupus erythematosus in skin","volume":"44","author":"Lehman","year":"2019","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"10.1016\/j.jtct.2026.01.009_bib0107","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jaad.2007.10.647","article-title":"CXCR3 <->ligand-mediated skin inflammation in cutaneous lichenoid graft-versus-host disease","volume":"58","author":"Wenzel","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.jtct.2026.01.009_bib0108","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1038\/jid.2008.96","article-title":"An IFN-associated cytotoxic cellular immune response against viral, self-, or tumor antigens is a common pathogenetic feature in \"interface dermatitis\"","volume":"128","author":"Wenzel","year":"2008","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.jtct.2026.01.009_bib0109","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/cup.14115","article-title":"Interleukin 36 expression in psoriasis variants and other dermatologic diseases with psoriasis-like histopathologic features","volume":"49","author":"Aquino","year":"2022","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jtct.2026.01.009_bib0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2025.05.002","article-title":"Differentiating psoriasis from eczema with interleukin-36 gamma immunohistochemistry on skin biopsy specimens: a retrospective, single-center validation and cohort study","author":"DaCosta","year":"2025","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.jtct.2026.01.009_bib0111","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.36849\/JDD.7500","article-title":"Off-label use of Janus kinase inhibitors in inflammatory cutaneous diseases","volume":"22","author":"Agarwal","year":"2023","journal-title":"J Drugs Dermatol"},{"issue":"5","key":"10.1016\/j.jtct.2026.01.009_bib0112","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/modpathol.2010.48","article-title":"CD20, AIF-1, and TGF-beta in graft-versus-host disease: a study of mRNA expression in histologically matched skin biopsies","volume":"23","author":"Wu","year":"2010","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.jtct.2026.01.009_bib0113","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.bbmt.2015.01.003","article-title":"National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: III. The 2014 biomarker working group report","volume":"21","author":"Paczesny","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.01.009_bib0114","unstructured":"FDA-NIH Biomarker Working Group. BEST (Biomarkers, EndpointS, and other Tools) resource 2016; Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK326791\/."},{"issue":"4","key":"10.1016\/j.jtct.2026.01.009_bib0115","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1182\/blood-2007-02-072389","article-title":"High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study","volume":"110","author":"Nash","year":"2007","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.jtct.2026.01.009_bib0116","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006203","article-title":"Cutaneous chronic graft-versus-host disease does not have the abnormal endothelial phenotype or vascular rarefaction characteristic of systemic sclerosis","volume":"4","author":"Fleming","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jtct.2026.01.009_bib0117","article-title":"Belumosudil reduces oral chronic graft-versus-host disease tissue inflammation and fibrosis: a ROCKstar companion study","author":"Sharma","year":"2025","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.jtct.2026.01.009_bib0118","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17030395","article-title":"The applications of machine learning in the management of patients undergoing stem cell transplantation: are we ready?","volume":"17","author":"Garuffo","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.jtct.2026.01.009_bib0119","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jtct.2021.03.033","article-title":"National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: IIa. The 2020 clinical implementation and early diagnosis working group report","volume":"27","author":"Kitko","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"6","key":"10.1016\/j.jtct.2026.01.009_bib0120","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jtct.2021.02.035","article-title":"National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2020 etiology and prevention working group report","volume":"27","author":"Williams","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"11","key":"10.1016\/j.jtct.2026.01.009_bib0121","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1182\/bloodadvances.2020001485","article-title":"Dickkopf-related protein 3 is a novel biomarker for chronic GVHD after allogeneic hematopoietic cell transplantation","volume":"4","author":"Inamoto","year":"2020","journal-title":"Blood Adv"},{"issue":"15","key":"10.1016\/j.jtct.2026.01.009_bib0122","doi-asserted-by":"crossref","DOI":"10.1172\/JCI168575","article-title":"Validated graft-specific biomarkers identify patients at risk for chronic graft-versus-host disease and death","volume":"133","author":"Logan","year":"2023","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.jtct.2026.01.009_bib0123","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0378-1119(99)00365-0","article-title":"Functional and structural diversity of the human Dickkopf gene family","volume":"238","author":"Krupnik","year":"1999","journal-title":"Gene"},{"issue":"24","key":"10.1016\/j.jtct.2026.01.009_bib0124","doi-asserted-by":"crossref","first-page":"6446","DOI":"10.1182\/blood-2011-05-354019","article-title":"Circulating B-cell activating factor level predicts clinical response of chronic graft-versus-host disease to extracorporeal photopheresis","volume":"118","author":"Whittle","year":"2011","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.jtct.2026.01.009_bib0125","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1158\/1078-0432.CCR-07-1290","article-title":"High levels of B-cell activating factor in patients with active chronic graft-versus-host disease","volume":"13","author":"Sarantopoulos","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.jtct.2026.01.009_bib0126","first-page":"298","article-title":"Red cell distribution width as a new prognostic biomarker in refractory chronic graft-versus-host disease","volume":"109","author":"Schulz","year":"2024","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.jtct.2026.01.009_bib0127","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.4049\/jimmunol.1601054","article-title":"Upregulation of IFN-inducible and damage-response pathways in chronic graft-versus-host disease","volume":"197","author":"Hakim","year":"2016","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.jtct.2026.01.009_bib0128","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1182\/blood-2005-03-1257","article-title":"Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease","volume":"106","author":"Zorn","year":"2005","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.jtct.2026.01.009_bib0129","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1038\/leu.2014.92","article-title":"Comparative analysis of FoxP3(+) regulatory T cells in the target tissues and blood in chronic graft versus host disease","volume":"28","author":"Imanguli","year":"2014","journal-title":"Leukemia"},{"issue":"19","key":"10.1016\/j.jtct.2026.01.009_bib0130","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1182\/blood.2024025337","article-title":"Defining pathogenic IL-17 and CSF-1 gene expression signatures in chronic graft-versus-host disease","volume":"145","author":"Boiko","year":"2025","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jtct.2026.01.009_bib0131","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/sj.jid.5701101","article-title":"Increased expression of Wnt2 and SFRP4 in Tsk mouse skin: role of Wnt signaling in altered dermal fibrillin deposition and systemic sclerosis","volume":"128","author":"Bayle","year":"2008","journal-title":"J Invest Dermatol"},{"issue":"24","key":"10.1016\/j.jtct.2026.01.009_bib0132","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10245820","article-title":"SFRP4 expression is linked to immune-driven fibrotic conditions, correlates with skin and lung fibrosis in SSc and a potential EMT biomarker","volume":"10","author":"Tinazzi","year":"2021","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.jtct.2026.01.009_bib0133","doi-asserted-by":"crossref","first-page":"100246","DOI":"10.1016\/j.xjidi.2023.100246","article-title":"Identification of fibroinflammatory and fibrotic transcriptomic subsets of human cutaneous sclerotic chronic graft-versus-host disease","volume":"4","author":"Rosenstein","year":"2024","journal-title":"JID Innov"},{"key":"10.1016\/j.jtct.2026.01.009_bib0134","doi-asserted-by":"crossref","first-page":"37635","DOI":"10.1038\/srep37635","article-title":"Overexpression of SerpinE2\/protease nexin-1 contribute to pathological cardiac fibrosis via increasing collagen deposition","volume":"6","author":"Li","year":"2016","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.jtct.2026.01.009_bib0135","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/jid.2014.489","article-title":"Epidermal Elafin expression is an indicator of poor prognosis in cutaneous graft-versus-host disease","volume":"135","author":"Bruggen","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.jtct.2026.01.009_bib0136","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jid.2023.08.026","article-title":"Sclerotic-type cutaneous chronic graft-versus-host disease exhibits activation of t helper 1 and OX40 cytokines","volume":"144","author":"Kim","year":"2024","journal-title":"J Invest Dermatol"},{"issue":"9","key":"10.1016\/j.jtct.2026.01.009_bib0137","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1182\/bloodadvances.2021004707","article-title":"RNA sequencing of chronic GVHD skin lesions defines shared and unique inflammatory pathways characterizing lichen planus and morphea","volume":"6","author":"Zouali","year":"2022","journal-title":"Blood Adv"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726000217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726000217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T21:15:56Z","timestamp":1781212556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636726000217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":123,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2666636726000217"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.01.009","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toward Better Response Assessment of Cutaneous Chronic Graft-Versus-Host Disease: A Report from the National Institutes of Health Consensus Project Task Force","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}